Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.063 | 0.7 |
mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.053 | 0.7 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |